Results 281 to 290 of about 116,133 (341)

Development and Validation of LC-MS/MS Method for Nintedanib and BIBF 1202 Monitoring in Plasma of Patients with Progressive Pulmonary Fibrosis Associated with Systemic Sclerosis. [PDF]

Pharmaceutics
Kiełczyńska A, Gilant E, Pawiński T, Szlaska I, Buś-Kwaśnik K, Pesta E, Kuc D, Kwiatkowska B.   +7 more
europepmc   +1 more source

Remyelination therapies are achievable in clinical practice-No. [PDF]

Mult Scler
Shirani A, Stuve O.
europepmc   +1 more source

Prognostic significance implications of aortic valve sclerosis in the development of aortic stenosis: a systematic review and meta-analysis. [PDF]

Open Heart
Myasoedova VA, Valerio V, Massaiu I, Bertolini F, Rusconi V, Marenzi G, Poggio P.   +6 more
europepmc   +1 more source

High-dose chemotherapy and transplantation of autologous CD34+ selected stem cells for progressive systemic sclerosis adjusted to cardiac and lung manifestation: an open-label, non-inferiority phase 2 trial

Ann‐Christin Pecher, Ina Koetter, K. Peis, Reinhild Klein, Claudia Lengerke, W. Vogel, Patrick Krumm, Marc Schmalzing, Stefan Wirths, J. Henes   +9 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Progressive Systemic Sclerosis

Regional Anesthesia and Pain Medicine, 1999
Background and Objectives At present, there is no reliable method for long-term treatment of severe pain from progressive systemic sclerosis (PSS) associated with Raynaud's phenomena leading to ischemia and ulcerations of the extremities.
C N, Lundborg, P V, Nitescu, L K, Appelgren, I D, Curelaru   +3 more
openaire   +3 more sources

Progressive Systemic Sclerosis

The British Journal of Radiology, 1965
Fifty-two cases of scleroderma have been investigated in the Diagnostic Radiology Department. The incidence of the various systemic manifestations has been discussed. It has been found that over 50 per cent of the patients had positive radiological changes in the colon. These are specific for scleroderma and consist of wide-necked pseudo diverticula in
R A, Harper, D C, Jackson
openaire   +2 more sources

Progressive Systemic Sclerosis (Scleroderma)

New England Journal of Medicine, 1953
THE skin manifestations of scleroderma have long been recognized and adequately described. These features are usually identified readily, particularly in the later phases of the disease when the spectacular, hardened, bound-down, wrinkleless appearance of the skin is so characteristic as to supply a descriptive name for the illness. This term refers to
P M, BEIGELMAN, F, GOLDNER, T B, BAYLES
openaire   +3 more sources

Progressive Systemic Sclerosis (Scleroderma)

Australasian Annals of Medicine, 1970
SummarySixteen cases of progressive systemic sclerosis (PSS) were studied in a large general hospital in Singapore from 1957 to 1967. Thirteen were Chinese and 3 Malays. The majority were middle‐aged housewives and half of the cases were seen less than six months after onset.
C H, Tay, O T, Khoo
openaire   +2 more sources

Progressive Systemic Sclerosis

Clinics in Rheumatic Diseases, 1983
To date, largely because of convenience, therapeutic trials in progressive systemic sclerosis have been few and largely short-term retrospective single institution studies. For the future, there is a pressing need to expand efforts in this area to include: controlled, prospective studies with adequate numbers of patients employing, if necessary, a ...
openaire   +4 more sources